Abivax (AAVXF) Operating Leases (2022 - 2025)

Abivax has reported Operating Leases for 4 years, with the latest figure at $2.9 million in Q4 2025.

• On a quarterly basis, Operating Leases rose 91.22% year-over-year to $2.9 million in Q4 2025; TTM through Dec 2025 was $2.9 million, a 91.22% increase from a year earlier, with the FY2025 full-year figure at $2.9 million, up 91.22% from the prior year.
• Operating Leases was $2.9 million for Q4 2025 at Abivax, roughly flat from $2.9 million in the prior quarter.
• The five-year high for Operating Leases was $2.9 million in Q3 2025, with the low at $407781.2 in Q4 2023.
• Average Operating Leases over 4 years is $1.7 million, with a median of $1.5 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2024: Operating Leases slumped 52.36% in 2023, then surged 275.0% in 2024.
• Over 4 years, Operating Leases stood at $855987.5 in 2022, then plunged by 52.36% to $407781.2 in 2023, then soared by 275.0% to $1.5 million in 2024, then soared by 91.22% to $2.9 million in 2025.
• The last three Operating Leases figures came in at $2.9 million (Q4 2025), $2.9 million (Q3 2025), and $1.5 million (Q4 2024), per Business Quant data.